S African athlete's gender eligibility trial wasn't fair

Kuwait Times

2 days ago

STRASBOURG: A top European court ruled Thursday that the Swiss judiciary did not give double Olympic champion Caster Semenya a fair trial when she contested a rule forcing her to lower her testosterone levels to be able to compete as a woman. However, the European Court of Human Rights (ECHR), in its final decision, said it could not determine whether or not the South African runner had suffered discrimination. Its verdict comes after a row over the gender of an Algerian boxing champion engulfed the 2024 Paris Olympics, and as the International Olympic Committee mulls reintroducing contested gender testing.
Semenya, 34, is classed as having 'differences in sexual development', but has always been legally identified as female. She has been unable to compete in her favored 800m category since 2018, after she refused to take drugs to reduce her testosterone levels under new rules from World Athletics, the governing body for track and field. Semenya told journalists the ECHR's decision was a 'positive outcome'. 'We need to respect athletes, we need to put their rights first,' said the athlete, who was Olympic 800m champion in 2012 and 2016 and world gold medallist in 2009, 2011 and 2017.
It was a reminder to leaders that 'priorities lie in the protection of athletes,' she added. Semenya has embarked on a long legal marathon to contest the World Athletics rule. The Lausanne-based Court of Arbitration for Sport ruled against her in 2019 and the decision was validated by the Swiss Federal Court in Lausanne in 2020. It judged that a testosterone level comparable to that of men gave female athletes 'an insurmountable advantage'. The ECHR said the Swiss court did not give the case a 'rigorous judicial review that was commensurate with the seriousness of the personal rights at issue', and had therefore breached Semenya's right to a fair trial under the European Convention on Human Rights. It ordered Switzerland to pay her 80,000 euros ($93,000) for expenses.
A lower chamber at the ECHR in 2023 ruled that Semenya was the victim of discrimination by the Court of Arbitration for Sport—even if it did not call into question the World Athletics rule, nor allow Semenya to return to competition without taking medication. Swiss authorities, supported by World Athletics, appealed to the European court's 17-member Grand Chamber, leading to Thursday's ruling.
The Grand Chamber, however, said it could not rule on any discrimination as the alleged offence did not fall under Switzerland's jurisdiction. Seema Patel, a sports law expert, said 'the Grand Chamber didn't go far enough to recognize all violations in this case'. 'But there is at least an alert to sport that convention rights must be respected,' she said. Antoine Duval, another legal scholar, said the ECHR had implied the World Athletics rule was disproportionate. Its judgment 'encourages intersex athletes affected by these rules to go before the Court of Arbitration for Sport and relaunch the debate', he said. There are many types of 'differences in sexual development', a group of rare conditions involving genes, hormones and reproductive organs.
Formerly known as intersexuality, they occur in approximately one in 1,000 to 4,500 births. Semenya was born with the '46 XY' chromosome, rather than the XX chromosome most women have.
Before the 2009 world championships, where Semenya won the 800m gold aged just 18, she was forced to undergo gender testing. She was then put on medication to reduce testosterone levels.
But Semenya said she felt like a 'human guinea pig' and vowed to never allow it again. Testosterone is produced by men and women but men produce 20 times more of the sex hormone. But how much the hormone boosts performance remains a matter of debate. --AFP